Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.100
+0.230 (12.30%)
At close: Jun 26, 2026, 4:00 PM EDT
2.100
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:55 PM EDT
Fate Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Fate Therapeutics stock have an average target of 5.70, with a low estimate of 2.20 and a high estimate of 8.00. The average target predicts an increase of 171.43% from the current stock price of 2.10.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Fate Therapeutics stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 6 | 6 | 6 | 6 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Mizuho Securities No rating | Mizuho Securities | Buy Maintains $8 | Buy | Maintains | $8 | +280.95% | Jun 22, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $6 | Buy | Reiterates | $6 | +185.71% | Jun 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +233.33% | Jun 8, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 4, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $2 → $2.2 | Hold | Reiterates | $2 → $2.2 | +4.76% | May 22, 2026 |
Financial Forecast
Revenue This Year
5.25M
from 6.65M
Decreased by -21.05%
Revenue Next Year
5.24M
from 5.25M
Decreased by -0.21%
EPS This Year
-1.03
from -1.15
EPS Next Year
-0.99
from -1.03
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.0M | 20.0M | |
| Avg | 5.2M | 5.2M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 140.7% | 281.2% | |
| Avg | -21.0% | -0.2% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.77 | -0.64 | |
| Avg | -1.03 | -0.99 | |
| Low | -1.21 | -1.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.